Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive Biomarker Profiling of the IFN-α Pathway in Amyotrophic Lateral Sclerosis Patient Biofluids

NCT07260981 is registered in ClinicalTrials.gov with Ulysses Neuroscience LTD as lead sponsor.

NCT NCT07260981
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07260981 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive Biomarker Profiling of the IFN-α Pathway in Amyotrophic Lateral Sclerosis Patient Biofluids
Lead sponsor
Ulysses Neuroscience LTD
Phase
Observational
Overall status
Completed
Start date
March 1, 2023
Completion date
January 18, 2025
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als - amyotrophic lateral sclerosis